Heterologous ChAdOx1 nCoV-19/BNT162b2 Prime-Boost Vaccination Induces Strong Humoral Responses among Health Care Workers

Despite limited data on safety and immunogenicity, heterologous prime-boost vaccination is currently recommended for individuals with ChAdOx1 nCoV-19 prime immunization in certain age groups. In this prospective, single-center study we included 166 health care workers from Heidelberg University Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Benning, Louise, Töllner, Maximilian, Hidmark, Asa, Schaier, Matthias, Nusshag, Christian, Kälble, Florian, Reichel, Paula, Buylaert, Mirabel, Grenz, Julia, Ponath, Gerald, Klein, Katrin, Zeier, Martin, Süsal, Caner, Schnitzler, Paul, Morath, Christian, Speer, Claudius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402499/
https://www.ncbi.nlm.nih.gov/pubmed/34451982
http://dx.doi.org/10.3390/vaccines9080857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402499/
https://www.ncbi.nlm.nih.gov/pubmed/34451982
http://dx.doi.org/10.3390/vaccines9080857

Ejemplares similares